|Adenosine 2B receptor expression on cancer cells promotes metastasis|
D Mittal, D Sinha, D Barkauskas, A Young, M Kalimutho, K Stannard, ...
Cancer research 76 (15), 4372-4382, 2016
|Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis|
J Jeffery, D Sinha, S Srihari, M Kalimutho, KK Khanna
Oncogene 35 (6), 683-690, 2016
|Mitotic slippage: an old tale with a new twist|
D Sinha, PHG Duijf, KK Khanna
Cell cycle 18 (1), 7-15, 2019
|CEP 55 is a determinant of cell fate during perturbed mitosis in breast cancer|
M Kalimutho, D Sinha, J Jeffery, K Nones, S Srihari, WC Fernando, ...
EMBO molecular medicine 10 (9), e8566, 2018
|Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer|
PV Raninga, AC Lee, D Sinha, YY Shih, D Mittal, A Makhale, AL Bain, ...
International journal of cancer 146 (1), 123-136, 2020
|Cep55 overexpression causes male‐specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling|
D Sinha, M Kalimutho, J Bowles, AL Chan, DJ Merriner, AL Bain, ...
The FASEB Journal 32 (9), 4984-4999, 2018
|Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition|
PV Raninga, A Lee, D Sinha, L Dong, KK Datta, X Lu, P Kalita-de Croft, ...
Theranostics 10 (12), 5259, 2020
|Enhanced dependency of KRAS‐mutant colorectal cancer cells on RAD 51‐dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae|
M Kalimutho, AL Bain, B Mukherjee, P Nag, DM Nanayakkara, SK Harten, ...
Molecular oncology 11 (5), 470-490, 2017
|Prophylactic and therapeutic strategies for Epstein–Barr Virus-associated diseases: emerging strategies for clinical development|
V Desari, D Sinha, MA Neller, C Smith, R Khanna
Expert reviews on vaccines 18 (5), 457-474, 2019
|Cep55 overexpression promotes genomic instability and tumorigenesis in mice|
D Sinha, P Nag, D Nanayakkara, PHG Duijf, A Burgess, P Raninga, ...
Communications biology 3 (1), 593, 2020
|Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras|
CGP Doss, S Debottam, C Debajyoti
Protoplasma 250, 787-792, 2013
|Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer|
M Kalimutho, D Sinha, D Mittal, S Srihari, D Nanayakkara, S Shafique, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 1-18, 2019
|Pretransplant cytomegalovirus-specific cellular immunity and risk of viral reactivation following lung transplantation: a prospective cohort study|
M Altaf, KE Lineburg, P Crooks, S Rehan, KK Matthews, MA Neller, ...
The Journal of infectious diseases 224 (2), 312-317, 2021
|'Off-the-shelf’allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies|
D Sinha, S Srihari, K Beckett, L Le Texier, M Solomon, A Panikkar, ...
Journal for ImmunoTherapy of Cancer 9 (2), 2021
|Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine|
CGP Doss, C Debajyoti, S Debottam
Cell biochemistry and biophysics 67, 1075-1079, 2013
|Studies on the dielectric properties of natural urinary stones|
D Sinha, K Anwar, K Kumari, S Jaishwal, S Madeshwaran, S Keshari, ...
Advanced Materials Research 584, 484-488, 2012
|The impact of gold nanoparticles on hTERT gene expression leading to termination of malignant tumor|
CGP Doss, C Debajyoti, S Debottam
Gene 493 (1), 140-141, 2012
|Joining forces: improving clinical response to cellular immunotherapies with small-molecule inhibitors|
D Sinha, C Smith, R Khanna
Trends in Molecular Medicine 27 (1), 75-90, 2021
|Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis|
B Rashidieh, B Shohayeb, AL Bain, PRJ Fortuna, D Sinha, A Burgess, ...
PLoS genetics 17 (10), e1009334, 2021
|Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients|
S Das, A Babu, T Medha, G Ramanathan, AG Mukherjee, UR Wanjari, ...
Medical Oncology 40 (5), 1-16, 2023